v3.26.1
Statements of Changes in Shareholders' Equity - USD ($)
Common Stock
IPO
Common Stock
Private placement
Common Stock
Additional paid-in capital
IPO
Additional paid-in capital
Private placement
Additional paid-in capital
Accumulated Deficit
IPO
Private placement
Over-allotment option
Total
Balance at the beginning at Dec. 31, 2023     $ 216     $ 24,784 $ (1,782)       $ 23,218
Balance at the beginning (in shares) at Dec. 31, 2023     2,156,250                
Issuance of additional founder shares     $ 14     1,652 (1,666)        
Issuance of additional founder shares (in shares)     143,750                
Net Income (Loss)             (25,850)       (25,850)
Balance at the end at Dec. 31, 2024     $ 230     26,436 (29,298)       (2,632)
Balance at the end (in shares) at Dec. 31, 2024     2,300,000                
Issuance of units $ 800 $ 24 $ 4 $ 79,999,200 $ 2,482,976 96   $ 80,000,000 $ 2,483,000   100
Issuance of units (in shares) 8,000,000 248,300 40,000         8,000,000 248,300 40,000  
Sale of 1,000,000 $15 strike warrants in private placement         $ 100,000       $ 100,000    
Issuance of advisor units     $ 1               1
Issuance of advisor units (in shares)     7,500                
Reclassification of offering costs           (1,481,032)         (1,481,032)
Common shares subject to possible redemption     $ (800)     (80,799,200)         (80,800,000)
Accretion of common shares subject to possible redemption           $ (328,476) (1,008,412)       (1,336,888)
Forfeiture of founder shares due to no over-allotment exercise by underwriter (in shares)     (300,000)                
Net Income (Loss)             1,426,980       1,426,980
Balance at the end at Dec. 31, 2025     $ 259       $ 389,270       $ 389,529
Balance at the end (in shares) at Dec. 31, 2025     10,295,800